NEW YORK, October 18, 2016 /PRNewswire/ --
Wrist wearable fitness trackers have gained a lot of popularity
over the last few years with a wide range of customers. While
popular, the question is whether or not wrist worn fitness trackers
and heart monitoring devices are accurate? According to a research
conducted by Cleveland Clinic physicians, such devices
are not as accurate as chest-worn heart monitors. Biotricity Inc.
(OTC: BTCY), Natus Medical Inc. (NASDAQ: BABY), Fitbit Inc. (NYSE:
FIT), Koninklijke Philips NV (NYSE: PHG), Medtronic PLC
(NYSE: MDT)
The research led by cardiac surgeon Marc
Gillinov, MD, explains how such devices work. The chest-worn
monitors are similar to electrocardiogram (EKG), which doctors use
for diagnostic purposes. The chest-worn heart monitor has two parts
- a transmitter, and a receiver worn on the wrist like a watch. The
transmitter picks up the electric signal and then sends an
electromagnetic signal containing heart rate data to the receiver,
which then displays the heart rate.
Biotricity Inc. (OTCQB: BTCY) announced today that the
company has received a 510(k) clearance from the U.S. Food and Drug
Administration (FDA) for a key component of its solution. This
clearance is another watershed moment in the company's quest to
market its remote cardiac monitoring solution comprised of the
bioflux software and device. By developing medical remote
monitoring solutions that help diagnose and manage chronic
diseases, Biotricity seeks to revolutionize the health industry by
bridging the gap in chronic care management. Biotricity Inc. is a
healthcare technology company dedicated to delivering innovative,
medically relevant biometric remote monitoring solutions
Waqaas Al-Siddiq, Founder and CEO of Biotricity said, "Achieving
an FDA clearance validates the capability of Biotricity to meet its
vision of developing a series of clinically accurate medical
devices that are applicable in both medical and home-based
settings. Receiving a 510(k) clearance is a significant
accomplishment towards our goal of enabling physicians to remotely
monitor and diagnose patients with cardiovascular disease and
coronary heart disease. More importantly, it is yet another step to
making this vision a reality."
"While wrist-worn fitness devices are incredibly popular and
valuable for the fitness and lifestyle markets, they are not
applicable for chronic patients. The reality is they are not
cleared by the FDA, and we believe some of them may not be capable
of reliably measuring heart rates," said Al-Siddiq. "Unlike these
light weight lifestyle/fitness devices, we aim to impact the
healthcare by targeting at-risk patients and to do that you need
medically relevant devices."
Fitbit Inc. (NYSE: FIT) popularity maybe slowing
over the last year as competition in the sector has intensified.
Fitbit's possible solution to problem is moving from fitness
trackers towards more sophisticated medical devices. As of right
now, the company's devices did not impress the Cleveland
Clinic physicians. According to the research Fitbit Charge HR
underestimated heart rate during vigorous exercises. Fitbit's push
into the medical field will test the accuracy of the company's
future devices, as it will involve the FDA and their approval
process.
For more professional medical purposes, for example in a
hospital setting, heart rate monitoring medical devices are also
quite diverse. Natus Medical Inc. (NASDAQ: BABY) is
in the newborn care business. The company provides products and
services used for the screening, diagnosis, detection, treatment,
monitoring and tracking of common medical ailments in newborn care.
The company has particularly innovative with monitoring devices.
One of the products, the Pocket-Dop 3 is a valuable tool for
monitoring the fetal heartbeat.
Companies like Koninklijke Philips NV (NYSE: PHG)
and Medtronic PLC (NYSE: MDT) have been the medical
devices business for decades, and it was only a matter of time
until they capitalize on wearable devices. Back in 2014 Medtronic
acquired Corventis, which made noninvasive cardiac sensors.
Medtronic then announced its first medical wearable device, the
SEEQ Mobile Cardiac Telemetry (MCT) System. Most of the devices
today are manufactured with the sophisticated sensors, which
monitor metabolic changes and generate results in seconds.
Subscribe Now! Watch us report from NYSE
https://www.youtube.com/FinancialBuzzMedia
For "The Latest Buzz in Financial News", SIGN UP & Visit:
http://www.FinancialBuzz.com
Follow us on Twitter for real time Financial News Updates:
https://twitter.com/financialbuzz
Follow and talk to us on
Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live
feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web
portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth
broadcasts on Stock News, Market Analysis and Company Interviews. A
pioneer in the financially driven digital space, video production
and integration of social media, FinancialBuzz.com creates 100%
unique original content. FinancialBuzz.com also provides financial
news PR branding, marketing and advertising for third parties for
disseminating news and original content through our unique media
platform that includes Newswire Delivery, Digital Advertising,
Social Media Relations, Video Production, Broadcasting, and
Financial Publications.
Please Note: FinancialBuzz.com is not a financial advisory or
advisor, investment advisor or broker-dealer and do not undertake
any activities that would require such registration. The
information provided on http://www.FinancialBuzz.com (the "Site")
is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content),
FinancialBuzz.com, a financial news media and pr marketing firm
enters into service agreements with the companies which are the
subject to the articles posted on the Site for advertising such
companies. Financialbuzz.com has signed a four month financial news
pr services agreement for ten thousand
dollars directly from the biotricity inc. We are not an
independent news media provider and therefore do not represent or
warrant that the information posted on the Site is accurate,
unbiased or complete. FinancialBuzz.com receives fees for producing
and presenting high quality and sophisticated content on this site
along with other financial news pr media services. Our fees may be
either a flat cash sum or negotiated number of securities of the
companies featured on this site, or a combination thereof. The
securities are commonly paid in segments, of which a portion is
received upon engagement and the balance is paid on or near the
conclusion of the engagement. FinancialBuzz.com agreed to a four
month financial news pr services agreement for ten thousand
restricted shares and twenty thousand warrants directly from
biotricity inc. FinancialBuzz.com does not undertake to update any
of the information on the Site or continue to post information
about any companies the information contained herein is not
intended to be used as the basis for investment decisions and
should not be considered as investment advice or a recommendation.
The information contained herein is not an offer or solicitation to
buy, hold or sell any security. FinancialBuzz.com, members and
affiliates are not responsible for any gains or losses that result
from the opinions expressed on the Site, company profiles,
quotations or in other materials or presentations that it publishes
electronically or in print. Investors accept full responsibility
for any and all of their investment decisions based on their own
independent research and evaluation of their own investment goals,
risk tolerance, and financial condition. FinancialBuzz.com. By
accessing this website and any pages thereof, you agree to be bound
by the Terms of Use and Privacy Policy, as may be amended from time
to time. None of the content issued by FinancialBuzz.com
constitutes a recommendation for any investor to purchase, hold or
sell any particular security, pursue a particular investment
strategy or that any security is suitable for any investor. This
publication is provided by FinancialBuzz.com. Each investor is
solely responsible for determining whether a particular security or
investment strategy is suitable based on their objectives, other
securities holdings, financial situation needs, and tax status. You
agree to consult with your investment advisor, tax and legal
consultant before making any investment decisions. We make no
representations as to the completeness, accuracy or timeless of the
material provided. All materials are subject to change without
notice. Information is obtained from sources believed to be
reliable, but its accuracy and completeness are not guaranteed. For
our full disclaimer, disclosure and Terms of Use. Please visit:
http://www.financialbuzz.com
For further information:
Media Contact: Danny A, info@financialbuzz.com ,
+1-877-601-1879
SOURCE FinancialBuzz.com